Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avidity Biosciences (RNA) Shares Issued: 2019-2025

Historic Shares Issued for Avidity Biosciences (RNA) over the last 4 years, with Sep 2025 value amounting to $831.7 million.

  • Avidity Biosciences' Shares Issued rose 156.89% to $831.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $836.9 million, marking a year-over-year increase of 4.51%. This contributed to the annual value of $762.2 million for FY2024, which is 1158.79% up from last year.
  • Latest data reveals that Avidity Biosciences reported Shares Issued of $831.7 million as of Q3 2025, which was up 21,943.73% from $3.8 million recorded in Q2 2025.
  • Over the past 5 years, Avidity Biosciences' Shares Issued peaked at $831.7 million during Q3 2025, and registered a low of -$500,000 during Q4 2024.
  • Moreover, its 3-year median value for Shares Issued was $38.1 million (2023), whereas its average is $184.5 million.
  • Per our database at Business Quant, Avidity Biosciences' Shares Issued skyrocketed by 141,682.35% in 2022 and then slumped by 99.19% in 2025.
  • Over the past 5 years, Avidity Biosciences' Shares Issued (Quarterly) stood at $174.4 million in 2021, then surged by 39.41% to $243.1 million in 2022, then declined by 0.46% to $38.1 million in 2023, then skyrocketed by 425.52% to -$500,000 in 2024, then skyrocketed by 156.89% to $831.7 million in 2025.
  • Its last three reported values are $831.7 million in Q3 2025, $3.8 million for Q2 2025, and $1.9 million during Q1 2025.